@article{14d56a9f6d3447838894492ba81dcf2e,
title = "Special Populations: Treatment-Resistant Depression in Children and Adolescents",
keywords = "Adolescents, Antidepressants, Children, Major depressive disorder, Novel treatments, Treatment-resistant depression",
author = "Ayvaci, {Emine Rabia} and Croarkin, {Paul E.}",
note = "Funding Information: Dr P.E. Croarkin has received research support from the Brain and Behavior Research Foundation , Mayo Clinic Foundation , National Institute of Mental Health , National Science Foundation, United States , Pfizer, United States , Neuronetics Inc ., and NeoSync, United States . He has received equipment support from Neuronetics Inc, and MagVenture, United States , Inc for investigator-initiated research. He has received material support from Myriad Genetics for investigator-initiated research. He has consulted for Engrail Therapeutics, Myriad Genetics, Procter & Gamble Company, and Sunovion. Dr R. Ayvaci has no disclosures. Funding Information: Dr P.E. Croarkin has received research support from the Brain and Behavior Research Foundation, Mayo Clinic Foundation, National Institute of Mental Health, National Science Foundation, United States, Pfizer, United States, Neuronetics Inc., and NeoSync, United States. He has received equipment support from Neuronetics Inc, and MagVenture, United States, Inc for investigator-initiated research. He has received material support from Myriad Genetics for investigator-initiated research. He has consulted for Engrail Therapeutics, Myriad Genetics, Procter & Gamble Company, and Sunovion. Dr R. Ayvaci has no disclosures.",
year = "2023",
month = jun,
doi = "10.1016/j.psc.2023.02.007",
language = "English (US)",
volume = "46",
pages = "359--370",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "2",
}